Direct medical costs associated with different lines of therapy for colorectal cancer patients

Author： Ray Saurabh Bonthapally Vijayveer Meyer Nicole M Miller Jeffrey D Bonafede Machaon M Curkendall Suellen M

ISSN： 1758-194X

Source： Colorectal Cancer, Vol.2, Iss.2, 2013-04, pp. : 121-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The costs of managing patients with advanced colorectal cancer in 10 different European centres - a frontier approach

By Neymark N. Adriaenssen I.

European Journal of Cancer, Vol. 35, Iss. 13, 1999-12 ,pp. : 1789-1795

Elsevier

Access to resources Recommend Favorite

Costs and outcomes associated with hospitalized cancer patients with neutropenic complications: A retrospective study

Experimental and Therapeutic Medicine, Vol. 2, Iss. 5, 2011-01 ,pp. : 859-866

Spandidos Publications

Access to resources Recommend Favorite

Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer

By Gao Zhiguang Guo Bomin Gao Renyuan Zhu Qingchao Wu Wen Qin Huanlong

Molecular Medicine Reports, Vol. 12, Iss. 4, 2015-10 ,pp. : 6119-6127

Spandidos Publications

Access to resources Recommend Favorite

Capecitabine as third line therapy in patients with advanced colorectal cancer

By Gubanski Michael Naucler Gisela Almerud Agneta Lideståhl Anders Lind Pehr A R M

Acta Oncologica, Vol. 44, Iss. 3, 2005-05 ,pp. : 236-239

Informa Healthcare

Access to resources Recommend Favorite

Combination therapy of S-1 and CDDP for patients with colorectal cancer

By Uchida Kazumi Hayashi Kazuhiko Kuramochi Hidekazu Nakajima Go Inoue Yuji Yamamoto Masakazu

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 11, 2007-11 ,pp. : 841-846

Springer Publishing Company

Access to resources Recommend Favorite